Overexpression of a new gene P28GANK confers multidrug resistance of gastric cancer cells (Q39880807)

15 September 2017

title

Overexpression of a new gene P28GANK confers multidrug resistance of gastric cancer cells (English)

1 reference

15 September 2017

1 reference

multiple drug resistance

1 reference

Xiaohua Li

1

1 reference

15 September 2017

Ying Zhang

2

1 reference

15 September 2017

Chen Xiong

3

1 reference

15 September 2017

Haifeng Jin

4

1 reference

15 September 2017

Bin Jing

5

1 reference

15 September 2017

Yafei Zhang

6

1 reference

15 September 2017

Daiming Fan

7

1 reference

15 September 2017

publication date

1 February 2009

1 reference

15 September 2017

1 reference

15 September 2017

volume

27

1 reference

15 September 2017

issue

2

1 reference

15 September 2017

page(s)

129-139

1 reference

Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F07357900802189816

Resistance mechanisms associated with altered intracellular distribution of anticancer agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802189816

From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802189816

Direct interaction between a quinoline derivative, MS-209, and multidrug resistance protein (MRP) in human gastric cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802189816

The multidrug resistance-associated protein gene confers drug resistance in human gastric and colon cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802189816

Apoptosis: a link between cancer genetics and chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802189816

Induction of apoptosis and/or necrosis following exposure to antitumour agents in a melanoma cell line, probably through modulation of Bcl-2 family proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802189816

Drug resistance in melanoma: mechanisms, apoptosis, and new potential therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802189816

Cisplatin: mode of cytotoxic action and molecular basis of resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802189816

cDNA cloning and functional analysis of p28 (Nas6p) and p40.5 (Nas7p), two novel regulatory subunits of the 26S proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802189816

Gankyrin is an ankyrin-repeat oncoprotein that interacts with CDK4 kinase and the S6 ATPase of the 26 S proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802189816

MAGE-A4 interacts with the liver oncoprotein gankyrin and suppresses its tumorigenic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802189816

Sequential changes in hepatocarcinogenesis induced by diethylnitrosamine plus thioacetamide in Fischer 344 rats: induction of gankyrin expression in liver fibrosis, pRB degradation in cirrhosis, and methylation of p16(INK4A) exon 1 in hepatocellular

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802189816

Novel insights into the INK4-CDK4/6-Rb pathway: counter action of gankyrin against INK4 proteins regulates the CDK4-mediated phosphorylation of Rb

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802189816

Overexpression of p28/gankyrin in human hepatocellular carcinoma and its clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802189816

Use of adenovirus-delivered siRNA to target oncoprotein p28GANK in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802189816

CIAPIN1 confers multidrug resistance by upregulating the expression of MDR-1 and MRP-1 in gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802189816

Tumor suppressor gene Runx3 sensitizes gastric cancer cells to chemotherapeutic drugs by downregulating Bcl-2, MDR-1 and MRP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802189816

Overexpression and significance of prion protein in gastric cancer and multidrug-resistant gastric carcinoma cell line SGC7901/ADR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802189816

Peloruside A does not bind to the taxoid site on beta-tubulin and retains its activity in multidrug-resistant cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802189816

Transcriptional regulators of the human multidrug resistance 1 gene: recent views

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802189816

P-glycoprotein, glutathione and glutathione S-transferase increase in a colon carcinoma cell line by colchicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802189816

Death and anti-death: tumour resistance to apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802189816

Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802189816

Dysregulation of apoptosis in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802189816

10.1080/07357900802189816

21 January 2018

Identifiers

DOI

1 reference

15 September 2017

1 reference